Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.

Liu Q, Mier JW, Panka DJ

Open source

DOI
10.1186/1476-4598-10-115
Published
2011 Sep 19
Container
Molecular cancer
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1476-4598-10-115,
  title = {Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.},
  author = {Liu Q and Mier JW and Panka DJ},
  year = {2011},
  journal = {Molecular cancer},
  doi = {10.1186/1476-4598-10-115},
  url = {https://doi.org/10.1186/1476-4598-10-115}
}

RIS

TY  - JOUR
TI  - Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
AU  - Liu Q
AU  - Mier JW
AU  - Panka DJ
PY  - 2011
JO  - Molecular cancer
DO  - 10.1186/1476-4598-10-115
UR  - https://doi.org/10.1186/1476-4598-10-115
ER  - 

APA

Q, L., JW, M., & DJ, P. (2011). Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.. Molecular cancer. https://doi.org/10.1186/1476-4598-10-115

Source records